These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 11279780)

  • 1. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
    Rowell NP; Williams CJ
    Cochrane Database Syst Rev; 2001; (1):CD002935. PubMed ID: 11279780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
    Rowell NP; Williams CJ
    Cochrane Database Syst Rev; 2001; (2):CD002935. PubMed ID: 11406051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.
    Rowell NP; Williams CJ
    Thorax; 2001 Aug; 56(8):628-38. PubMed ID: 11462066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
    Stevens R; Macbeth F; Toy E; Coles B; Lester JF
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD002143. PubMed ID: 25586198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic overview of radiation therapy effects in non-small cell lung cancer.
    Sirzén F; Kjellén E; Sörenson S; Cavallin-Ståhl E
    Acta Oncol; 2003; 42(5-6):493-515. PubMed ID: 14596509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
    Nguyen LN; Komaki R; Allen P; Schea RA; Milas L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy of stage I and II non-small cell lung cancer (NSCLC).
    Zierhut D; Bettscheider C; Schubert K; van Kampen M; Wannenmacher M
    Lung Cancer; 2001 Dec; 34 Suppl 3():S39-43. PubMed ID: 11740992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WITHDRAWN: Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
    Rowell NP; Williams C
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002935. PubMed ID: 25756660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
    Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
    Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemoradiotherapy in non-small cell lung cancer.
    Rowell NP; O'rourke NP
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002140. PubMed ID: 15495029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical radiotherapy in stage I non-small cell lung cancer (NSCLC)--Singapore National Cancer Centre experience.
    Low JSh; Koh WY; Yap SP; Fong KW
    Ann Acad Med Singap; 2007 Sep; 36(9):778-83. PubMed ID: 17925989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative radiotherapy regimens for non-small cell lung cancer.
    Lester JF; Macbeth FR; Toy E; Coles B
    Cochrane Database Syst Rev; 2006 Oct; (4):CD002143. PubMed ID: 17054152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status.
    Maguire J; Khan I; McMenemin R; O'Rourke N; McNee S; Kelly V; Peedell C; Snee M
    Eur J Cancer; 2014 Nov; 50(17):2939-49. PubMed ID: 25304298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
    Moore S; Leung B; Wu J; Ho C
    Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
    Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer.
    Jeremic B; Classen J; Bamberg M
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):119-130. PubMed ID: 12182981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
    Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment the efficacy of postoperative radiotherapy in the patients with non-small cell lung cancer. Retrospective study].
    Chmielewska E; Jodkiewicz Z; Karwański M
    Pneumonol Alergol Pol; 2012; 80(2):109-19. PubMed ID: 22370979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer: analysis of data from the literature.
    Kong C; Guo WJ; Zha WW; Zhu XZ; Huang SF; Zhang YW; Xu JH; He X
    Lung Cancer; 2014 Apr; 84(1):7-12. PubMed ID: 24548340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.